On 4 February the Gabinete Técnico Farmacéutico M. Camps and consultancy Azierta organise the webinar "Vigilance and post-marketing of medical devices".
This training, which will be held online for registered users -attendance is free of charge, subject to registration- will provide an overview of regulation and the steps to be taken to carry out PS monitoring.
The market surveillance and monitoring are an essential part of the marketing of medical devices.This is a sector in continuous innovation and of great importance in the European and Spanish market.
The webinar will be moderated by:
- Mercè Camps. CEO and founder of the Technical Pharmaceutical Cabinet MCamps
- Olegario Cuevas. Healthcare Business Manager at Azierta
The webinar presentation will be conducted by:
- Silvia de Andrés. Medical Devices Officer
- Alberto Orós. Technical Consultant
Surveillance and marketing of medical devices:
webinar programme
-
-
- Introduction
- Surveillance system
- Incident management
- Security corrective actions (FSCA) and security notices (FSN)
- Trend reporting
- Post-market surveillance system
- Periodic Security Update Report (PSUR)
- Post Market Monitoring Report (PMSR)
- Post-marketing clinical follow-up
-
Latest articles in our blog
Cosmetorium 2018: SEQC celebrates the 3rd edition of its cosmetics congress
The Spanish Society of Cosmetic Chemists (SEQC) has organised, at the end of September, the 3rd edition of the Cosmetorium event, from the idea to the product. On 26 and 27 September, the SEQC has invited the cosmetics sector to Cosmetorium 2018, which will be held in...
Counterfeit cosmetics on the internet: an unfinished business for the industry
Counterfeit cosmetics are, nowadays, one of the biggest problems for the most important companies in our sector. These copies of perfumes, facial peelings and anti-wrinkle creams, which have traditionally been sold at very low prices in the market, have been...
Health Authorisation for PS advertising: Salut closes the face-to-face route
The Department of Health of Catalonia has abolished the in-person channel for applications for health authorisation for advertising of PS and IVDs. Since 1 July, the Generalitat has only accepted applications submitted through the telematic channel, i.e., through the...